Alexis Kayser

Dr. Tom Mihaljevic envisions AI "not on the surface of the current system, but in the center of the future system."

After two years of tweaks and slow-scaling pilots, Abridge is bringing AI to the nurses' stations.

Care quality alone isn't a business case anymore, marketing leaders say.

The CEO of the FDA's new AI partner said he's "never seen the agency work this fast."

Abridge's nursing platform was "absolutely" a bigger challenge than the physician equivalent, Dr. Shiv Rao told Newsweek.

Altera's VP says patients still underestimate the risks of non-HIPAA-compliant LLMs—and doctors are going to have to educate them.

Health care organizations need "financial flexibility," according to Joe Kight. Here's how he recommends achieving it.

Faris Flourney agrees that "bad actors" are a problem in hospice care—but warns that new restrictions could restrict access.

Roxanna Gapstur says monetizing innovations developed through the system's new tech partnership is "not out of the question."

Employers can't shirk responsibility for novel weight loss drugs forever, executives argued at a recent Newsweek event.